148 related articles for article (PubMed ID: 3091274)
1. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
[TBL] [Abstract][Full Text] [Related]
2. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL
J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
[TBL] [Abstract][Full Text] [Related]
3. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW; Horetsky RL
Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma.
Kreider JW; Howell LE; Bartlett GL
Cell Immunol; 1985 Jun; 93(1):26-37. PubMed ID: 3922632
[TBL] [Abstract][Full Text] [Related]
5. Helper and suppressor functions of panned populations of immune peritoneal T cells with reactivity to the rat mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW
Cell Immunol; 1988 Mar; 112(1):200-13. PubMed ID: 2449978
[TBL] [Abstract][Full Text] [Related]
6. Systemic adoptive transfer of immunity and low-dose irradiation eradicate metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Christensen ND; Welsh P
Int J Cancer; 1985 Aug; 36(2):217-24. PubMed ID: 3160672
[TBL] [Abstract][Full Text] [Related]
7. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
[TBL] [Abstract][Full Text] [Related]
8. Role of T-cell subsets in the destruction of established metastases of 13762A rat mammary adenocarcinoma.
Howell LE; Kreider JW; Bartlett GL
J Natl Cancer Inst; 1986 Jul; 77(1):187-93. PubMed ID: 3487670
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
[TBL] [Abstract][Full Text] [Related]
10. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
11. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
Huber S; Lucas ZJ
Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
[TBL] [Abstract][Full Text] [Related]
12. Membrane phenotype of the rat cytotoxic T lymphocyte.
Gilman SC; Rosenberg JS; Feldman JD
J Immunol; 1982 Sep; 129(3):1012-6. PubMed ID: 6980913
[TBL] [Abstract][Full Text] [Related]
13. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
14. Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.
Bonaventure J; Nigam VN; Brailovsky CA
Cancer Immunol Immunother; 1985; 20(2):167-74. PubMed ID: 3849979
[TBL] [Abstract][Full Text] [Related]
15. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
16. Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression.
Frey AB; Appleman LJ
Clin Immunol Immunopathol; 1993 Nov; 69(2):223-33. PubMed ID: 8403560
[TBL] [Abstract][Full Text] [Related]
17. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
[TBL] [Abstract][Full Text] [Related]
18. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
[TBL] [Abstract][Full Text] [Related]
19. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
20. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.
Cavallo F; Giovarelli M; Gulino A; Vacca A; Stoppacciaro A; Modesti A; Forni G
J Immunol; 1992 Dec; 149(11):3627-35. PubMed ID: 1358974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
